Asia Pharma R&D Leaders Summit 2017

The Pharma and Biotech sectors are at a pivotal point in their evolution. Pharmaceutical companies are likely to continue to increase the percentage of their R&D work that is outsourced in Asia. This trend will continue to be driven by the pursuit of Open Innovation in University-Industrial Partnership, Improving R&D cost efficiency as well as effectiveness. Beyond generating one-off savings, the emphasis will move to streamlining the outsourcing operating model, risk management, complexity management and lean process improvement.